A TASMAN Expedition: Development of a Questionnaire to Assess Specific Self-Management Abilities

Figures & data

Table 1 Main Patient’s Characteristics

Characteristics	COPD (N=100)
Sex (male/female)	58/41 (n=1 unknown)
Age (years)	69.68±9.74
Educational level	Low: 36 (36%)
	Medium: 39 (39%)
	High: 23 (23%)
	Unknown: 2 (2%)
COPD duration	1–3 years: 20 (20%)
	More than 3 years: 75 (75%)
	Unsure: 5 (5%)
Self-reported COPD severity	39.27±26.3

Abbreviation: COPD, chronic obstructive pulmonary disease.

Table 2 Correlations Between Self-Management Abilities, Self-Efficacy and Illness Perception and Proactive Coping

		GSES	IPQ-CONCERNS	UPCC
SMAS TOTAL	Pearson Correlation	.318*	−.230**	.426*
	Sig. (2-tailed)	0.001	0.026	0
	N	98	94	97

Notes: *Correlation is significant at the 0.01 level (2-tailed). ^**Correlation is significant at the 0.05 level (2-tailed).

Abbreviations: SMAS, Self-Management Ability Scale; GSES, General Self-Efficacy Scale; IPQ- concerns, Illness Perception Questionnaire Concerns; UPCC, Utrecht Proactive Coping Competence scale.

Table 3 Inter-Item Correlations Selected Items

	UPCC_5	UPCC_6	UPCC_8	UPCC_9	UPCC_12	UPCC_17
UPCC_5	1	0.604	0.471	0.444	0.562	0.528
UPCC_6	0.604	1	0.53	0.544	0.669	0.535
UPCC_8	0.471	0.53	1	0.677	0.533	0.634
UPCC_9	0.444	0.544	0.677	1	0.671	0.654
UPCC_12	0.562	0.669	0.533	0.671	1	0.622
UPCC_17	0.528	0.535	0.634	0.654	0.622	1
	GSES_1	GSES_3	GSES_4	GSES_5	GSES_6	GSES_7	GSES_8	GSES_9	GSES_10
GSES_1	1	0.575	0.566	0.521	0.633	0.482	0.424	0.392	0.539
GSES_3	0.575	1	0.618	0.495	0.679	0.503	0.401	0.453	0.447
GSES_4	0.566	0.618	1	0.531	0.624	0.508	0.543	0.601	0.478
GSES_5	0.521	0.495	0.531	1	0.547	0.566	0.631	0.661	0.61
GSES_6	0.633	0.679	0.624	0.547	1	0.567	0.501	0.466	0.527
GSES_7	0.482	0.503	0.508	0.566	0.567	1	0.509	0.674	0.568
GSES_8	0.424	0.401	0.543	0.631	0.501	0.509	1	0.661	0.542
GSES_9	0.392	0.453	0.601	0.661	0.466	0.674	0.661	1	0.623
GSES_10	0.539	0.447	0.478	0.61	0.527	0.568	0.542	0.623	1

Abbreviations: UPCC, Utrecht Proactive Coping Competence scale; GSES, General Self-Efficacy Scale.

Figure 1 The final instrument “TASMAN”; the developed 16 questions to assess patient’s self-management abilities.